Utilidad clínica de las biopsias aleatorias en el diagnóstico y tratamiento del tumor vesical no-músculo invasivo: revisión sistemática y metaanálisis-Reference-Cited by-同舟云学术

Utilidad clínica de las biopsias aleatorias en el diagnóstico y tratamiento del tumor vesical no-músculo invasivo: revisión sistemática y metaanálisis

Published:2018-06 Issue:5 Volume:42 Page:285-298
ISSN:0210-4806
Container-title:Actas Urológicas Españolas
language:es
Short-container-title:Actas Urológicas Españolas

Author:

Subiela J.D.,Palou J.,Esquinas C.,Fernández Gómez J.M.,Rodríguez Faba O.

Publisher

Elsevier BV

Subject

Urology

Reference47 articles.

1. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: Update 2016;Babjuk;Eur Urol.,2017

2. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol.,2006

3. Multivariate analysis of the prognostic factors of primary superficial bladder cancer;Millan-Rodriguez;J Urol.,2000

4. Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder;Lerner;Urol Oncol.,2012

5. [Significance of random biopsies of healthy mucosa in superficial bladder tumor];Fernandez Gomez;Arch Esp Urol.,2000

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Location‐specific diagnostic efficiency of photodynamic diagnosis‐guided biopsy in bladder mapping biopsies;International Journal of Urology;2024-08-02

2. Expression of Preferentially Expressed Antigen in Melanoma, a Cancer/Testis Antigen, in Carcinoma In Situ of the Urinary Tract;Diagnostics;2023-12-10

3. Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group;Journal of Clinical Oncology;2023-12-10

4. Precise diagnosis and treatment of non-muscle invasive bladder cancer - A clinical perspective;Frontiers in Oncology;2023-01-31

5. Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models;Bladder Cancer;2022-12-14